CD40 expression in epidermal tumors

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 569-572

  Viac, J ^a   Schmitt, D ^a   Claudy, A ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

CD40 antigen; Epidermal tumors; Keratinocytes

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39;

ANTIGEN EXPRESSION; ARTICLE; BASAL CELL CARCINOMA; CELL INFILTRATION; CELL INTERACTION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; INFLAMMATION; KERATINOCYTE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TUMOR CELL; TUMOR ESCAPE;

ANTIGENS, CD40; ANTIGENS, NEOPLASM; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CONDYLOMATA ACUMINATA; HUMANS; SKIN NEOPLASMS; WARTS;

EID: 0031043773     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Stamenkovic I, Clark EA and Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403-1410, 1989.
2. Banchereau J, Bazan F, Brière F, Galizzi JP, van Kooten C, Liu YJ, Rousset F and Sealand S: The CD40 antigen and its ligand. Annu Rev Immunol 12: 881-922, 1994.
3. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A and Gray D: Activated human T cells express a ligand for the B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 22: 2573-2578, 1992.
4. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA and Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11: 4313-4321, 1992.
5. Van Kooten C and Banchereau J: CD40-CD40 Ligand: a multifunctional receptor-ligand pair. Adv Immunol 61: 1-77, 1996.
6. Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK Lederman S and Chess L: Ligation of CD40 on fibroblast induces CD54 (ICAM-1) and CD 106 (VCAM-1) up-regulation and IL-6 production and proliferation. Leuk Biol 58: 209-216, 1995.
7. Gaspari, AA, Sempowski, GD, Chess PR, Gish J and Phipps RP: Cultured human keratinocytes express functional CD40 that mediates protein tyrosine kinase-dependent transmembrane signals and costimulates resting T-lymphocyte proliferation. (abst) J Invest Dermatol 106: 924, 1996.
8. Dezutter-Dambuyant C, Schmitt D, Staquet MJ, Gaucherand M, Cambazard F and Thivolet J: DMC1: a monoclonal antibody produced from histiocytosis X cells which reacts with the native CD 1 a molecule of human epidermal Langrhans cells. Hybridoma 8: 199-208, 1989.
9. Viac J, Chardonnet Y, Euvrard S and D Schmitt: Epidermotropism of T cells correlates with intercellular adhesion molecule (ICAM- 1) expression in human papillomavirus (HPV)-induced lesions. J Pathol 168: 301-306, 1992.
10. Karmann K, Hughes CC, Scheduler J, Fanslow WC and Pober JS: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92: 4342-4346, 1995.
11. Galy AHM and Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149: 775-782, 1992.
12. Caux C, Massacrier C, Vanbervliet B, Dubois B, van Kooten C, Durand I and Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180: 1263-1272, 1994.
13. Peguet-Navarro J, Dalbiez-Gauthier C, Rattis FM, Van Kooten C, Banchereau J and Schmitt D: Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 155: 4241-4247, 1995.
14. Grabbe S, Beissert S, Schwartz T and Gransteín RD: Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?. Immunol Today 16: 117-121, 1995.
15. Smolle J, Soyer HP, Ehall R, Bartenstein S and Kerl H: Langerhans cell density in epithelial skin tumours correlates with epithelial differentiation but not with the peritumoral infiltrate. J Invest Dermatol 87: 477-479, 1986.
16. Bergfelt L, Larko O and Lindberg M: Density and morphology of Langerhans cells in basal cell carcinoma. Brit J Dermatol 127: 575-579, 1991.
17. Viac J, Chardonnet Y, Chignol MC. Schmitt D: Papillomaviruses, warts, carcinoma and Langerhans cells. In vivo 7: 207-212, 1993.
18. Nickoloff BJ, Turka LA: Immunological functions of nonprofessional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 15: 464-469, 1994.
19. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfield RW, Kiener PA and Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 182: 33-40, 1995.
20. Viac J, Schmitt D and Claudy A: Expression of adhesion receptors in epidermal tumors: correlation with TNFα expressing cells. Anticancer Res 15: 551-556, 1995.
21. Casamayor-Pallala M, Khan M and MacLennan ICM: A subset of CD4+ memory T cells contains preformed CD4U ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med 181: 1293-1301, 1995.
22. Castle BE, Kishimoto K, Stearns C, Brown ML and Kehry MR: Regulation of expression of the ligand for CD40 on T helper lymphocytes, J Immunol 151: 1777-1788, 1993.